Episode Description
Listen to the episode on a streaming platform by clicking one of the links below:
Q1 earnings from the four largest publicly traded hospital operators—HCA, Tenet, UHS, and CHS—showed soft headline volumes, but the softness was a mix of one-offs (shorter flu season, winter storms) layered on top of the predicted decline due to the expiration of ACA enhanced premium tax credits.
The weather and respiratory effects are temporary, but the payer mix erosion from exchange losses is permanent and expected to worsen through 2026.
High-acuity outpatient migration is now the dominant capital story, with all four operators leaning hard into ASC acquisitions and de novos.
The most striking takeaway is what the calls didn't dwell on: OBBBA barely came up, even as many nonprofit health system boards have made it the dominant frame for 2026 strategy. The for-profits are betting that commercial mix and balance sheet strength make Medicaid policy impact less existential.
UnitedHealthcare announced it will eliminate prior authorization for roughly 30% of services requiring advance approval by year-end—with an emphasis on outpatient services—paralleling similar pledges from other major payers as part of a voluntary commitment with HHS and CMS.
Whether this is substantive or PR depends on what's actually on the list, which has not yet been disclosed. A previously announced rural provider carve-out may matter more, given how much rural hospitals with thin margins stand to gain from reduced administrative burden.
By easing friction on outpatient services while leaving inpatient utilization management intact, UHC is widening the administrative gap between settings—sharpening the strategic pressure on health systems around ambulatory capacity and ASC investment, and giving physicians yet another reason to prefer working outside the hospital.
CMS recently proposed CJR-X, a mandatory nationwide bundled payment model for lower extremity joint replacement taking effect October 1, 2027—extending the original CJR model’s two-sided risk structure to most IPPS hospitals.
The savings playbook still runs through post-acute spend, but the easy reductions have largely been harvested. CMS itself acknowledges this by trimming the target price discount from 3% to 2%. For systems where post-acute utilization has already structurally shifted, CJR-X is less a savings opportunity than a downward adjustment to LEJR economics they'll need to offset elsewhere.
Paired with TEAM, CJR-X signals that CMS has validated a template it's likely to keep using: mandatory episode pricing on high-volume, high-cost procedures, with regional benchmarks engineered to extract savings from whatever lever is available.
Delays in HHS processing of J-1 visa waivers threaten to force hundreds of foreign-trained physicians out of the U.S. by a July 30 deadline, jeopardizing placements in designated provider shortage areas. The pressure compounds a separate $100K H-1B visa fee hike that has already caused 64% of AHA member hospitals to limit or pause foreign physician recruitment.
The impact will fall hardest on the systems least able to absorb it—rural providers, safety-net systems, and those with heavy Medicaid mix—and will worsen access in the specialties J-1 waivers are reserved for (primary care, pediatrics, OB/GYN, behavioral health), which also happen to be the upstream referral channels and relationship-builders that health systems can least afford to lose.
Advocacy and litigation are the likeliest paths to resolution, but neither moves quickly: three lawsuits and a bipartisan fee exemption bill are all stalled, and election-year politics make standalone action unlikely. The recent quiet reversal of the physician travel ban after coordinated pressure from AHA, AMA, NRHA, and state AGs offers a template—but only if stakeholders mobilize before the deadline.
CMS Administrator Mehmet Oz directed all 50 state Medicaid directors to revalidate program providers, expanding a fraud crackdown that had previously focused on Democratic-led states.
Beyond the immediate compliance push, the initiative may also serve a broader narrative purpose: reinforcing concerns about Medicaid integrity in ways that could support future spending reductions.
The audits could squeeze the smaller partners health systems depend on, whose thinner margins and limited compliance infrastructure leave them more exposed.
About Our Host
Anika Rasheed
Anika is a Senior Analyst on the Strategy Catalyst team.